Avidity Biosciences, Inc. (RNA)

Avidity Biosciences Revenue

Avidity Biosciences had revenue of $10.87M in the twelve months ending March 31, 2024, with 12.50% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.54M with 58.67% year-over-year growth. In the year 2023, Avidity Biosciences had annual revenue of $9.56M with 3.64% growth.

• Revenue (ttm): $10.87M
• Revenue Growth: +12.50%
• P/S Ratio: 259.37
• Revenue / Employee: $42,964
• Employees: 253
• Market Cap: 2.82B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.56M	336.00K	3.64%
Dec 31, 2022	9.22M	-102.00K	-1.09%
Dec 31, 2021	9.33M	2.54M	37.41%
Dec 31, 2020	6.79M	4.47M	192.67%
Dec 31, 2019	2.32M	1.94M	511.87%
Dec 31, 2018	379.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.